Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

No change in [¹¹C]CUMI-101 binding to 5-HT(1A) receptors after intravenous citalopram in human

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Similar serotonin-2A receptor binding in rats with different coping styles or levels of aggression

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Acute social defeat does not alter cerebral 5-HT2A receptor binding in male Wistar rats

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Transient activation of mTOR following forced treadmill exercise in rats

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Direct comparison of [(18) F]MH.MZ and [(18) F]altanserin for 5-HT(2A) receptor imaging with PET

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Intradural artery dilation during experimentally induced migraine attacks

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Extensive astrocyte metabolism of γ-aminobutyric acid (GABA) sustains glutamine synthesis in the mammalian cerebral cortex

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Transcranial low-frequency pulsating electromagnetic fields (T-PEMF) as post-concussion syndrome treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
The main objective of this study was to determine the sensitivity of [¹¹C]CUMI-101 to citalopram challenge aiming at increasing extracellular 5-HT. CUMI-101 has agonistic properties in human embryonic kidney 293 cells transfected with human recombinant 5-HT(1A) receptors (Hendry et al. [2011] Nucl Med Biol 38:273-277; Kumar et al. [2006] J Med Chem 49:125-134) and has previously been demonstrated to be sensitive to bolus citalopram in monkeys (Milak et al. [2011] J Cereb Blood Flow Metab 31:243-249). We studied six healthy individuals. Two PET-scans were performed on the same day in each individual before and after constant infusion of citalopram (0.15 mg/kg). The imaging data were analyzed using two tissue compartment kinetic modeling with metabolite corrected arterial input and Simplified Reference Tissue Modeling using cerebellum as a reference region. There was no significant difference in regional distribution volume or non-displaceable binding potential values before and after citalopram infusion. The mean receptor occupancy was 0.03 (range -0.14 to 0.17). Our data imply that [¹¹C]CUMI-101 binding is not sensitive to citalopram infusion in humans.
OriginalsprogEngelsk
TidsskriftSynapse (New York)
Vol/bind66
Udgave nummer10
Sider (fra-til)880-4
Antal sider5
ISSN0887-4476
DOI
StatusUdgivet - okt. 2012

ID: 36484310